Misoprostol is a synthetic prostaglandin E 1 analogue that is used off label for a variety of purposes in the practice of Obstetrics and Gynaecology which includes medical termination of pregnancy, medical management of abortion, artificial induction of labour, ripening of cervix before surgical procedures, and the treatment of postpartum haemorrhage. So, due to its wide ranging applications in reproductive health, misoprostol is on the model list of essential medicines of World Health Organization. The main focus of this article is to evaluate the potential use of misoprostol in Obstetrics and Gynaecology.
INTRODUCTION
Misoprostol is sold under the brand name Cytotec. It is a medication which is used to prevent and treat stomach ulcers, induce labour, cause an abortion and to treat postpartum haemorrhage due to poor contraction of uterus 1. Its effectiveness for abortion is between 66% and 90% and is often used with mifepristone or methotrexate 2. It is administered orally to treat gastric ulcers but for labour induction or abortion, it is taken either in the cheek, under the tongue or places in vagina 3 the effects of misoprostol are dose dependent and it includes cervical softening and dilation, contraction of uterus, nausea, vomiting, diarrhea, fever and chills 4. However it has various other advantages over other synthetic prostaglandins analogues like: its low cost, long shelf life, lack of need of refrigerator and its worldwide availability.
Routes of administration of Misoprostol:
Various routes of administration are oral, vaginal, sublingual, buccal or rectal. Comparisons of oral and vaginal administration have shown that vaginal administration is associated with slower absorption. It is also associated with overall greater exposure to drug and greater effects on cervix and uterus.
Sublingual pattern show greater absorption and high peaks levels.
Buccal pattern show lower area under the curve and has lower side effects. Nonetheless, buccal and vaginal routes have similar effects on uterine tone and activity.
Medical abortion:
It has been reported that 600mg of oral mifepristone with 400µg of oral misoprostol 48 hrs later for pregnancies up to 49 days of gestation is approved by FDA in 2000 5 . Success rate of these regimes ranges from 95% to 98% with failure due to ongoing pregnancy is 1% approximately. Medical termination of pregnancy necessarily involves heavy bleeding and cramping as the pregnancy is expelled. Other side effects include nausea, vomiting, fever and chills. The death rate for mifepristone abortion is 1 per 10000 women, that too due to fatal sepsis 7 . When
mifepristone is not available, misoprostol is used alone.
Cervical ripening before surgical abortion:
Misoprostol is a proven cervical ripening agent prior to first trimester surgical abortion 6 .
Use of misoprostol in hysteroscopy:
The main aim of using misoprostol in hysteroscopy is to prevent complications of mechanical dilations such as cervical laceration, uterine perforation and creation of false passage. Studies have shown that misoprostol leads to a much greater dilation, decreased need of more dilation and reduced the rate of cervical laceration in premenopausal women 8. The greatest benefits were seen in nulliparous women and with operative hysteroscopy.
Induction of labour with a viable Fetus
In comparison with placebo, misoprostol causes cervical ripening before induction with oxytocin 9, 10 . It is administrated vaginally and the used dose is 25µg every 4 hours as needed, with a maximum dose of 150µg 11 . Primary outcomes included rate of vaginal delivery within 24 hours, incidences of uterine hyperstimulation with fetal heart rate changes, rate of cesarean delivery, and risk of serious adverse event in mother or fetus.
Post partum haemorrahage:
Apart from its uterine properties, misoprostol is used to treat post partum haemorrahages. Studies have shown that 1000µg of rectal administration of misoprostol when given to patients controlled post partum haemorrhage within 3 minutes 12 .
Conclusions:
In a nutshell, misoprostol have many implicatons in obstrectics and gynaecology. Research is going on its potential use to apply in different complications. Its low cost and easy use makes it a potential drug to improve women's health worldwide.
